FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to ophthalmology, can be used for prediction of progression of myopia acquired in schools in 10-14 and 15-17 year old children. Blood serum is analysed for cartilage glycoprotein-39 with the use of sandwich-type enzyme immunoassay. If its concentration is within 34.7-53.4 ng/ml in 10-14-year-old children and 22-56.3 ng/ml in 15-17-year-old children, a permanent course of myopia is predicted. The concentration 18.5-33.9 ng/ml in 10-14-year-old children and 53.7-69 ng/ml in 15-17-year-old children enables to predict a progressive course of myopia.
EFFECT: use of the invention improves accuracy of the prediction of clinical course.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF MYOPIA TRANSITION TO PROGRESSIVE FORM | 2009 |
|
RU2408890C1 |
| METHOD OF PREDICTING OUTCOME OF LASER INTRASTROMAL KERATOMILEUSIS IN CASE OF HIGH DEGREE MYOPIA | 2009 |
|
RU2391670C1 |
| METHOD OF HUMAN BIOPSY MATERIAL AND EXCRETE ANALYSIS FOR CHITINASE-LIKE PROTEIN YKL-40 | 2009 |
|
RU2423707C2 |
| METHOD FOR FORECASTING DEVELOPMENT OF PERIPHERAL VITREOCHORIORETINAL DYSTROPHIES ASSOCIATED WITH PROGRESSIVE MYOPIA IN CHILDREN | 1995 |
|
RU2089089C1 |
| METHOD OF MYOPIA PROGRESSION PROGNOSTICATING | 1994 |
|
RU2079136C1 |
| DIAGNOSTIC TECHNIQUE FOR SEVERITY OF KNEE JOINT OSTEOARTHROSIS | 2013 |
|
RU2530631C2 |
| METHOD FOR PREDICTING THE FLOW OF RHEUMATOID UVEITIS | 2005 |
|
RU2287164C1 |
| METHOD FOR FORECASTING SEVERITY OF EARLY PREECLAMPSY | 2021 |
|
RU2753463C1 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOME OF PENETRATING KERATOPLASTY | 2011 |
|
RU2444733C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT AND PROGRESSION OF SCOLIOSE BY THE LEVEL OF SEROTONIN IN THE BLOOD SERUM OF CHILDREN AND ADOLESCENTS AGED FROM 3 TO 15 YEARS | 2021 |
|
RU2771873C1 |
